Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PNRC1 divergent transcript (PNRC1-DT) is a long non-coding RNA (lncRNA) gene located at the PNRC1 locus, distinct from the protein-coding PNRC1 gene[4][6]. Unlike PNRC1, which encodes a nuclear receptor coactivator implicated in tumor suppression and rRNA processing regulation[1][3][6], PNRC1-DT is an RNA molecule believed to arise from divergent transcription at the locus and does not encode a functional protein. Its biological function, disease roles, and therapeutic relevance remain undetermined. There is frequent confusion between PNRC1-DT (the non-coding transcript) and PNRC1 (the nuclear receptor coactivator protein), but they are scientifically and functionally distinct. If you require information about the protein-coding PNRC1, which acts as a nuclear receptor coactivator and has emerging roles in cancer biology, please clarify, as that is a true molecular target with established literature[1][3][6]. For PNRC1-DT, data is limited and it is not considered a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PNRC1 divergent transcript (PNRC1-DT).